Medical News

RSS

New IVIG trial can reduce OCD symptoms in children with PANDAS

Criteria for a broadened syndrome of acute onset obsessive compulsive disorder (OCD) have been proposed by a National Institutes of Health scientist and her colleagues. The syndrome, Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), includes children and teens that suddenly develop on-again/off-again OCD symptoms or abnormal eating behaviors, along with other psychiatric symptoms - without any known cause.

26 Mar 2012

New UNC study estimates that 1.8B people still use unsafe water

Recent widespread news coverage heralded the success of a United Nations' goal of greatly improving access to safe drinking water around the world.

26 Mar 2012

BiO2 Medical completes $13.7M Series B round of funding

BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award.

26 Mar 2012

Palomar Health offers new patient-friendly loan program

Palomar Health is offering a new patient-friendly loan program called ClearBalance that gives patients an affordable option to pay their out-of-pocket hospital expenses over an extended period.

26 Mar 2012

Periodontal treatment linked with decrease in hospital admissions, medical care costs

Today, during the 41st Annual Meeting & Exhibition of the American Association for Dental Research (AADR), held in conjunction with the 36th Annual Meeting of the Canadian Association for Dental Research, an abstract titled "Periodontal Therapy Reduces Hospitalizations and Medical Care Costs in Diabetics" to determine if periodontal treatment was associated with the number of hospitalizations and cost of medical care among diabetics with periodontal disease.

26 Mar 2012

New method for measurement of aggregated beta-amyloid in AD

An international team of researchers have developed a new method for measurement of aggregated beta-amyloid - a protein complex believed to cause major nerve cell damage and dysfunction in Alzheimer's disease. The new method might facilitate diagnosis and detection as well as development of drugs directed against aggregated beta-amyloid.

26 Mar 2012

GenVec announces data from respiratory syncytial virus vaccine program

GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the "Keystone Symposium on Viral Immunity and Host Gene Influence", which is taking place in Keystone, Colorado from March 21-26, 2012.

26 Mar 2012

TPPF introduces PPACAction.com website

The Texas Public Policy Foundation announces the launch of PPACAction.com, a special website devoted to live coverage of next week's U.S. Supreme Court argument in Florida v. HHS. The case, to be taken up by the Court March 26 through 28, involves the constitutionality of the Patient Protection and Affordable Care Act (PPACA) signed into law by President Barack Obama in March 2010.

26 Mar 2012

Researchers identify gene that influences how we respond to flu infection

A genetic finding could help explain why influenza becomes a life-threating disease to some people while it has only mild effects in others. New research led by the Wellcome Trust Sanger Institute has identified for the first time a human gene that influences how we respond to influenza infection.

26 Mar 2012

MicroRNAs linked to imminent threat of heart attack

Researchers at the Intermountain Medical Center Heart Institute have, for the first time ever, made a connection between tiny genetic molecules called microRNAs and the imminent threat of a heart attack, according to a new study.

26 Mar 2012

Men with type 2 diabetes more likely to develop major cardiovascular events

According to a new study by researchers at Brigham and Women's Hospital (BWH), men with type 2 diabetes treated with insulin without a history of cardiovascular disease (CVD) were at higher risk for major cardiovascular events (e.g., death, heart attack, stroke) compared with men who had a history of CVD.

26 Mar 2012

Toshiba to showcase Infinix-i vascular X-ray product line at SIR annual meeting

Committed to developing technology to make vascular procedures faster, easier and safer, Toshiba America Medical Systems, Inc. introduces new software for its Infinix-i vascular X-ray systems, enabling high-speed 3D reconstruction and low-contrast imaging.

26 Mar 2012

Islet Sciences acquires DTI

Islet Sciences, Inc., a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced the closing of the acquisition of DiaKine Therapeutics, Inc., a biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and complications related to diabetes which is now the Company's wholly owned subsidiary.

26 Mar 2012

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.

26 Mar 2012

OAA, AOA form SUN alliance

The American Optometric Association (AOA) and the Opticians Association of America (OAA), with sponsorship from Luxottica and The Vision Council, have formed a SUN alliance designed to empower practices and businesses with the training and information needed to educate and prescribe appropriate sun protection for every patient.

26 Mar 2012

FDA Advisory Committee to review Repligen's SecreFlo NDA on May 31

Repligen Corporation today announced that the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company's New Drug Application (NDA) for SecreFlo for the improved detection of pancreatic duct abnormalities in combination with magnetic resonance imaging (MRI) in patients with pancreatitis.

26 Mar 2012

Researchers pinpoint new mechanism that potently activates T-cells in leprosy

UCLA researchers pinpointed a new mechanism that potently activates T-cells, the group of white blood cells that play a major role in fighting infections.

26 Mar 2012

ImpactRx announces acquisition of AlphaDetail

ImpactRx, a Symphony Technology Group (STG) company, and the pioneer in measuring the impact of promotion on physicians' attitudes and prescribing behavior, announced today that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping.

26 Mar 2012

International Alzheimer's experts unite for global effort

The world’s leading Alzheimer’s disease researchers and clinicians will gather in Melbourne this week to agree on standardisation and validation of important diagnostic and prognostic parameters used in Alzheimer’s research centres around the globe.

25 Mar 2012

Nerve pain patients in Wales gain access to first of a kind treatment which can provide lasting pain relief

For the first time NHS patients in Wales with peripheral nerve pain (known as peripheral neuropathic pain) can be treated with a patch containing capsaicin, which can provide at least 12 weeks pain relief following a single 30- or 60-minute application.

25 Mar 2012